Hyperphosphorylation of the protein tau, a MAP linked with neurodegeneration, promotes destabilization of microtubules in Alzheimer's disease which makes MAPs promising targets for therapeutic approaches to Alzheimer's disease [4]. The gene discussed is C3orf62; the disease is early-onset autosomal dominant Alzheimer disease.